Dermatological Manifestations in Immunocompromised Pediatric Patients on Chemotherapy: A Cross-sectional, Observational Study by Tulika Rai, Rajendra Kumar Mahawar, Priyanka Aggarwal

Subjects: “…chemotherapy…”
Get full text

Paradoxical Association of Postoperative Plasma Sphingosine-1-Phosphate with Breast Cancer Aggressiveness and Chemotherapy by Rajesh Ramanathan, Ali Raza, Jamie Sturgill, Debra Lyon, Jessica Young, Nitai C. Hait, Kazuaki Takabe

“…Plasma S1P levels are paradoxically suppressed in aggressive breast cancer and during adjuvant chemotherapy, which raises the possibility that postoperative plasma S1P levels do not reflect S1P secretion from resected breast cancer.…”
Get full text

An integrated cellular and sub-cellular model of cancer chemotherapy and therapies that target cell survival by Alexis B. Cook, Daniel R. Ziazadeh, Jianfeng Lu, Trachette L. Jackson

“…Here we present a multiscale modeling framework for investigating the synergism between traditional chemotherapy and targeted therapies aimed at critical regulators of apoptosis.…”
Get full text

Impact of Neoadjuvant Chemotherapy and Preoperative Irradiation on Early Complications in Direct-to-Implant Breast Reconstruction by Ji Won Hwang, Su Min Kim, Jin-Woo Park, Kyong-Je Woo

Subjects: Get full text

Leukemia in a child with juvenile idiopathic arthritis and relapse of arthritis following chemotherapy completion by Shree Hasitha Koneru, Mahesh Janarthanan, Vaishnavi Saminathan, Julius Xavier Scott

Get full text

Survival benefits of adjuvant chemotherapy after conversion surgery in patients with advanced pancreatic cancer by Yoon Suk Lee, Jang Won Lee, Hak Jun Kim, Jung Won Chun, Jong-Chan Lee, Dong Kee Jang, Jin-Hyeok Hwang, Young Ae Kim, Sang Myung Woo

“…However, maintaining the same regimens as preoperative chemotherapy was a significant factor, with HRs of 0.67 [95% CI 0.47–0.95, P = 0.02] from cancer diagnosis and 0.69 [95% CI 0.49–0.98, P = 0.04] from conversion surgery.ConclusionsThe incorporation of adjuvant chemotherapy with the same preoperative regimen could be an effective strategy for patients with advanced PC who would undergo conversion surgery.…”
Get full text

The use of medicinal plants and herbal medicines for patients in chemotherapy in an oncology center of Ijuí/RS by Gislaine Tisott Dal Molin, Aline Williens Cavinatto, Christiane de Fátima Colet

Subjects: “…plant species. cancer. chemotherapy.…”
Get full text

Photodynamic Antimicrobial Chemotherapy for Root Canal System Asepsis: A Narrative Literature Review by P. Diogo, T. Gonçalves, P. Palma, J. M. Santos

Get full text

Nonlinear and Robust Control Strategy Based on Chemotherapy to Minimize the HIV Concentration in Blood Plasma by Ricardo Aguilar-López, Rigel Valentín Gómez-Acata, Gerardo Lara-Cisneros, Ricardo Femat

Get full text

Radiomics-based Machine Learning Approach to Predict Chemotherapy Responses in Colorectal Liver Metastases by Yuji Miyamoto, Takeshi Nakaura, Mayuko Ohuchi, Katsuhiro Ogawa, Rikako Kato, Yuto Maeda, Kojiro Eto, Masaaki Iwatsuki, Yoshifumi Baba, Toshinori Hirai, Hideo Baba

Subjects: Get full text

Hyperthermic Intraperitoneal Chemotherapy with Melphalan: A Summary of Clinical and Pharmacological Data in 34 Patients by Lana Bijelic, Paul H. Sugarbaker, O. Anthony Stuart

“…Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a treatment option for peritoneal metastases. …”
Get full text

Network analysis of the symptoms of posttraumatic stress disorder in patients undergoing chemotherapy for colorectal cancer by Yi Zhou, Wen Teng, Liang Luo, Ping Zhou, Guidi Fan, Haiying Liu

Subjects: Get full text

In Situ Thrombosis of Small Pulmonary Arteries in Pulmonary Hypertension Developing after Chemotherapy for Malignancy by Kay Maeda, Yoshikatsu Saiki, Shigeo Yamaki

“…A few reports have provided histopathological insight into pulmonary hypertension developing after antitumor chemotherapy. In general, plexogenic pulmonary arteriopathy is a commonly observed finding in patients with severe pulmonary hypertension. …”
Get full text

Hyperthermic intraperitoneal chemotherapy (HIPEC) increases risk of local anesthetic systemic toxicity (LAST) by Masahiko Tsuchiya, Hiroharu Takesada, Koh Mizutani

Get full text

Trypsin-instructed bioactive peptide nanodrugs with cascading transformations to improve chemotherapy against colon cancer by Can Wu, Xiao Wei Zhang, Manman Wang, Jinpan Sun, Jianfei Chen, Yanbin Guan, Xin Pang

Subjects: Get full text

Effects of acupuncture-related intervention on chemotherapy-induced peripheral neuropathy and quality of life: An umbrella review by Mei-Ling Yeh, Chin-Che Hsu, Matthew Lin, Chuan-Ju Lin, Jaung-Geng Lin

Subjects: Get full text

Oral health status in children undergoing chemotherapy at Erbil city: A case control study. by Zahraa Emaad Ahmed, Sazan Sherdl Salim

“… Background: Chemotherapy is a well-known effective treatment for cancer but is associated with many side effects including that of the dental and oral aspects, which have an impact on the overall/general health-related quality of life. …”
Get full text

Oncological outcomes in non-seminomatous testicular tumors and residual mass after cisplatin-based chemotherapy by María A. Ocampo-Gómez, María C. Moreno-Matson, David Ruiz-Londoño, Marino Cabrera, Rodolfo Varela

Subjects: “…Residual mass. Cisplatin based chemotherapy.…”
Get full text

Cost-effectiveness analysis of durvalumab with chemotherapy and maintenance durvalumab with or without olaparib for advanced endometrial cancer by Jiahao Zhang, Jianying Lei, Caicong You, Wu Fu, Bin Zheng, Hongfu Cai, Maobai Liu, Na Li

“…Abstract This study evaluates the cost-effectiveness of adding durvalumab to chemotherapy, with subsequent maintenance either with olaparib (DOCT) or without olaparib (DCT), versus chemotherapy alone (CT) as a first-line treatment for advanced endometrial cancer (EC) in the United States, stratified by mismatch repair deficiency (dMMR) and proficiency (pMMR). …”
Get full text

MYST3/CREBBP Rearranged Acute Myeloid Leukemia after Adjuvant Chemotherapy for Breast Cancer by Arjun Gupta, Mrinal M. Patnaik, Harris V. Naina

“…The MYST3/CREBBP AML tends to develop within 2 years of adjuvant chemotherapy, especially for breast cancer, without preceding myelodysplasia. …”
Get full text